On behalf of the Cardio-Oncology Working Group of the Egyptian Society of Cardiology, the International Cardio-Oncology Society (ICOS), and the Cardiology Department of 57357 Children’s Cancer Hospital, it is our great honor and privilege to welcome you to the Third Egyptian Cardio-Oncology Conference (ECOC) 2026, taking place on October 22–23, 2026, at the prestigious Steigenberger Hotel Cairo.
This year’s conference represents a defining milestone in our journey. ECOC 2026 is the first conference to be held following the official inauguration of the International Cardio-Oncology Society (ICOS) Egypt Chapter, marking a transformative step forward for cardio-oncology in Egypt and the region. It reflects our collective commitment to advancing multidisciplinary collaboration, elevating standards of care, and aligning our clinical and research efforts with the global cardio-oncology community.
We are deeply honored to collaborate with ICOS—the world’s leading and most influential society dedicated to cardiovascular care in cancer patients. This partnership not only strengthens our regional impact but also brings unparalleled international expertise, fostering a powerful exchange of knowledge and experience.
ECOC 2026 will gather an exceptional faculty of distinguished international and regional experts, delivering a rich and forward-looking scientific program. Attendees can expect cutting-edge discussions spanning early detection and structured surveillance of cardiotoxicity, innovations in multimodality imaging and biomarkers, management of cardiovascular complications associated with immunotherapy, as well as important advances in pediatric and adolescent cardio-oncology. The program will also highlight evolving strategies in cardioprotection and long-term survivorship care.
More than a conference, ECOC 2026 is a dynamic platform for inspiration, collaboration, and progress. It is where ideas converge, partnerships are forged, and the future of cardio-oncology in Egypt and beyond is shaped.
We look forward to warmly welcoming you to Cairo for two exceptional days of science, dialogue, and global connection.
Dr. Daniel Addison is an Associate
Professor in the Department of Internal Medicine at UT Southwestern Medical
Center. He serves as the Director of Translational Research in the Division of
Cardiology and as the Associate Director for Survivorship and Outcomes Research
at the Harold C. Simmons Comprehensive Cancer Center. In recognition of his
contributions to the field, he also holds the prestigious Audre and Bernard
Rapoport Endowed Chair in Cardiovascular Research.
Dr. Syed Mahmood is the System Director of Cardio-Oncology at St. Francis Heart Center and Catholic Health Services of Long Island. He specializes in managing cardiovascular toxicities related to cancer therapies, with his research focusing on immunotherapy-associated myocarditis. He serves as Principal Investigator of a multi-center CAR T-cell registry and has published in The Lancet, JAMA, and other leading journals. He founded the cardio-oncology program at Weill Cornell Medicine. He completed training at MGH, Brigham and Women’s Hospital, and Weill Cornell, and is certified in Cardiovascular Diseases, Heart Failure, and Cardio-Oncology.
Dr. Alexander Lyon is a consultant cardiologist and head of the Cardio-Oncology service at the Royal Brompton Hospital since it was created in 2011. Alex is director of the Cardio-Oncology Centre of Excellence which received a gold award by the International Cardio-Oncology Society (ICOS) in 2021. Alex is an executive board member of ICOS and he was co-chair of the first European Society of Cardiology Cardio-Oncology Guidelines. He is the immediate past chair of the ESC Council of Cardio-Oncology, the past president of the British Cardio-Oncology Society, and he is currently deputy editor of the European Heart Journal. Alex has published over 250 scientific papers in peer-reviewed journals with a current H-index of 69.
Dr. Ahmed Abuzaid is a Clinical Imaging Cardiologist and Director of Advanced Imaging and Nuclear Cardiology at the Alaska Heart and Vascular Institute (AHVI). He specializes in noninvasive and multimodality cardiovascular imaging, with expertise in hypertrophic cardiomyopathy, amyloidosis, and structural heart disease. He completed his internal medicine residency at Creighton University, followed by fellowships in cardiovascular disease at Thomas Jefferson University/Christiana Care and in advanced echocardiography and cardiovascular imaging at the University of California, San Francisco. He holds multiple board certifications, including in echocardiography, nuclear cardiology, vascular interpretation, and cardiovascular MRI.
Dr. Hadi Skouri is a specialist in Advanced Heart Failure and Cardio-Oncology at Sheikh Shakhbout Medical City–Mayo Clinic in the UAE, where he has served since December 2021. Prior to that, he spent over 16 years at the American University of Beirut Medical Center (2007–2023), holding various academic and clinical positions. He is currently Professor of Clinical Medicine at Balamand University School of Medicine and Adjunct Professor of Cardiology at both Khalifa University and Gulf Medical University. Dr. Skouri completed advanced heart failure and heart transplantation fellowships at the Cleveland Clinic and Mayo Clinic in Rochester. He serves as Chair of the Heart Failure Working Group of the Lebanese Society of Cardiology and is an active member of the Acute Heart Failure, Education, and Membership Committees of the Heart Failure Association of the European Society of Cardiology.
Dr. Abdelrahman Ali is a cardiology fellow at the University of Texas Medical Branch (UTMB) in Galveston, with specialized training in cardio-oncology from the University of Texas MD Anderson Cancer Center. He serves as the Honorary Chair of the Scientific Committee for the Egyptian Cardio-Oncology Congress, where he plays a leading role in shaping the scientific vision of the conference. His research focuses on cancer therapy–related cardiac dysfunction, immune checkpoint inhibitor myocarditis, and heart failure management in oncology patients, with publications in JACC: CardioOncology, Circulation: Cardiovascular Interventions, European Heart Journal, and Cardio-Oncology.Â
Dr. Mohamed El Khashab is an Advanced Heart Failure and Transplant Consultant at Cleveland Clinic Abu Dhabi’s Heart, Vascular & Thoracic Institute. Prior to joining CCAD, he practiced in the United States for eight years, serving as Director of the Cardiac Intensive Care Unit at Kansas University Medical Center and later as an Advanced Heart Failure Cardiologist at Pulse Heart Institute in Washington. He completed his fellowship in Advanced Heart Failure and Transplant Cardiology at Northwestern University Feinberg School of Medicine, following training in internal medicine at Creighton University and general cardiology at John H. Stroger Hospital in Chicago.
Dr. Jessica Sturgess is an American Board-Certified Consultant Cardiologist. Her clinical interests include cardiovascular disease prevention, cardiometabolic health, clinical lipidology, and cardiovascular care in women and athletes. She received her medical degree from Saint Louis University School of Medicine and completed her internal medicine residency at Rush University Medical Center. Dr. Sturgess pursued cardiovascular disease fellowships at the University at Buffalo, the University of Kansas School of Medicine, and the University of Missouri–Kansas City, where she completed advanced subspecialty training in preventive cardiology.